Filing Details

Accession Number:
0001209191-12-046623
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-09-25 14:39:42
Reporting Period:
2012-07-30
Filing Date:
2012-09-25
Accepted Time:
2012-09-25 14:39:42
Original Submission Date:
2012-08-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1504466 R Kirk Maples C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Svp, Program Management No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-07-30 3,000 $6.03 15,652 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This is NOT a new sale transaction - this is an amendment is SOLELY for the purpose of adding a Power of Attorney (Written Authorization - authority of person signing). All other information remains the same and correct, as filed on7/30/12.